» Articles » PMID: 34472371

Efficacy of Physical Exercise to Offset Anthracycline-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis of Clinical and Preclinical Studies

Overview
Date 2021 Sep 2
PMID 34472371
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background Physical exercise is an intervention that might protect against doxorubicin-induced cardiotoxicity. In this meta-analysis and systematic review, we aimed to estimate the effect of exercise on doxorubicin-induced cardiotoxicity and to evaluate mechanisms underlying exercise-mediated cardioprotection using (pre)clinical evidence. Methods and Results We conducted a systematic search in PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) databases. Cochrane's and Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) risk-of-bias tools were used to assess the validity of human and animal studies, respectively. Cardiotoxicity outcomes reported by ≥3 studies were pooled and structured around the type of exercise intervention. Forty articles were included, of which 3 were clinical studies. Overall, in humans (sample sizes ranging from 24 to 61), results were indicative of exercise-mediated cardioprotection, yet they were not sufficient to establish whether physical exercise protects against doxorubicin-induced cardiotoxicity. In animal studies (n=37), a pooled analysis demonstrated that forced exercise interventions significantly mitigated in vivo and ex vivo doxorubicin-induced cardiotoxicity compared with nonexercised controls. Similar yet slightly smaller effects were found for voluntary exercise interventions. We identified oxidative stress and related pathways, and less doxorubicin accumulation as mechanisms underlying exercise-induced cardioprotection, of which the latter could act as an overarching mechanism. Conclusions Animal studies indicate that various exercise interventions can protect against doxorubicin-induced cardiotoxicity in rodents. Less doxorubicin accumulation in cardiac tissue could be a key underlying mechanism. Given the preclinical evidence and limited availability of clinical data, larger and methodologically rigorous clinical studies are needed to clarify the role of physical exercise in preventing cardiotoxicity in patients with cancer. Registration URL: https://www.crd.york.ac.uk/prospero; Unique identifier: CRD42019118218.

Citing Articles

Exercise training partly ameliorates cardiac dysfunction in mice during doxorubicin treatment of breast cancer.

Uurasmaa T, Bourdin P, Nammas W, Latifi S, Liljenback H, Saraste A J Transl Med. 2025; 23(1):89.

PMID: 39838445 PMC: 11748283. DOI: 10.1186/s12967-025-06108-y.


Cardiovascular Considerations Before Cancer Therapy: Gaps in Evidence and Expert Panel Recommendations.

Raisi-Estabragh Z, Murphy A, Ramalingam S, Scherrer-Crosbie M, Lopez-Fernandez T, Reynolds K JACC CardioOncol. 2024; 6(5):631-654.

PMID: 39479317 PMC: 11520216. DOI: 10.1016/j.jaccao.2024.07.017.


Research Progress on the Mechanism, Monitoring, and Prevention of Cardiac Injury Caused by Antineoplastic Drugs-Anthracyclines.

Chen Y, Yang W, Cui X, Zhang H, Li L, Fu J Biology (Basel). 2024; 13(9).

PMID: 39336116 PMC: 11429024. DOI: 10.3390/biology13090689.


An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity.

Xie S, Sun Y, Zhao X, Xiao Y, Zhou F, Lin L Front Pharmacol. 2024; 15:1406247.

PMID: 38989148 PMC: 11234178. DOI: 10.3389/fphar.2024.1406247.


TITAN Trial: A Randomized Controlled Trial of a Cardiac Rehabilitation Care Model in Breast Cancer.

Kirkham A, Mackey J, Thompson R, Haykowsky M, Oudit G, McNeely M JACC Adv. 2024; 2(6):100424.

PMID: 38939428 PMC: 11198667. DOI: 10.1016/j.jacadv.2023.100424.


References
1.
Arnold M, Rutherford M, Bardot A, Ferlay J, Andersson T, Myklebust T . Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019; 20(11):1493-1505. PMC: 6838671. DOI: 10.1016/S1470-2045(19)30456-5. View

2.
Glick D, Barth S, Macleod K . Autophagy: cellular and molecular mechanisms. J Pathol. 2010; 221(1):3-12. PMC: 2990190. DOI: 10.1002/path.2697. View

3.
Hayward R, Lien C, Jensen B, Hydock D, Schneider C . Exercise training mitigates anthracycline-induced chronic cardiotoxicity in a juvenile rat model. Pediatr Blood Cancer. 2011; 59(1):149-54. DOI: 10.1002/pbc.23392. View

4.
Ascensao A, Lumini-Oliveira J, Machado N, Ferreira R, Goncalves I, Moreira A . Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats. Clin Sci (Lond). 2010; 120(1):37-49. DOI: 10.1042/CS20100254. View

5.
Kirkham A, Eves N, Shave R, Bland K, Bovard J, Gelmon K . The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT. Breast Cancer Res Treat. 2017; 167(3):719-729. DOI: 10.1007/s10549-017-4554-4. View